Aethlon Medical Inc. | Income Statement

Fiscal year is April-March. All values USD Thousands.
2014
2015
2016
2017
2018
2019
Sales/Revenue
1,623.80
762.40
886.60
392.10
149.60
229.60
SG&A Expense
4,658.60
4,717.90
5,232.90
6,458.00
4,945.10
6,197.90
EBIT
3,055.90
3,992.90
-
6,098.40
4,831.10
5,999
Unusual Expense
9,952.20
2,546.40
-
904.00
507.10
-
Interest Expense
430.90
440.30
573.80
304.30
361.60
220.50
Pretax Income
13,439.00
6,979.50
4,958.60
7,306.70
5,699.80
6,219.50
Consolidated Net Income
13,439.00
6,979.50
4,958.60
7,306.70
5,699.80
6,219.50
Net Income
13,357.20
6,797.20
4,872.30
7,276.10
5,679.60
6,194.70
Net Income After Extraordinaries
13,357.20
6,797.20
4,872.30
7,276.10
5,679.60
6,194.70
Net Income Available to Common
13,357.20
6,797.20
4,872.30
7,276.10
5,679.60
6,194.70
EPS (Basic)
3.44
1.22
0.66
0.94
0.46
0.34
Basic Shares Outstanding
3,881.20
5,594.40
7,393.70
7,764.20
12,317.10
18,124.70
EPS (Diluted)
3.44
1.21
0.66
0.94
0.46
0.34
Diluted Shares Outstanding
3,881.20
5,594.40
7,393.70
7,764.20
12,317.10
18,124.70
EBITDA
3,034.80
3,955.50
4,346.30
6,066.00
4,795.50
5,968.30
Non-Operating Interest Income
0.10
-
-
-
-
-
Minority Interest Expense
81.70
182.30
86.30
30.60
20.30
24.80

About Aethlon Medical

View Profile
Address
9635 Granite Ridge Drive
San Diego California 92123
United States
Employees -
Website http://www.aethlonmedical.com
Updated 07/08/2019
Aethlon Medical, Inc. is a therapeutic technology company, which focuses on addressing global health and biodefense needs. It develops Aethlon Hemopurifier, a medical device that targets the elimination of circulating viruses and tumor-secreted exosomes that promote cancer progression. The firm operates through two segments: Aethlon and ESI.